Supported by: Federal Ministry of Research, Technology and Space

The DNA of the development of gene and gene-editing therapies

 

Seminar fee

Participation in the seminars is free of charge for scientists, university staff, and students throughout Germany. Please register using your university email address.

The project is funded by the GO-Bio initial program of the BMFTR.

Please note that your registration is binding. You can cancel your registration up to one week before the course begins without giving a reason.

Target audience

This project is suitable for master's students, doctoral candidates, postdoctoral researchers, and all academic staff in the life and natural sciences, medicine, and related fields who want to further develop their applicable ideas or inventions, ideally to the point of commercialization.

Program

The program and invitation to the seminar can be found here as a PDF file.

Speakers

Dr Timo Faltus studied biology, specialising in genetic engineering and cell culture, as well as law, specialising in genetic engineering and medical law, at the University of Frankfurt am Main. At Martin Luther University Halle, he led an interdisciplinary research project on the ethical, legal and social issues surrounding genome editing and served as an expert on genetic engineering law for the German Bundestag.

Dr Anne-Kristin Heninger is a co-founder of Seamless Therapeutics and heads up the company’s operations in Germany. She played a key role in developing Seamless Therapeutics’ business and financial strategies and successfully secured the company’s intellectual property rights. She began her career in genome editing at the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden.

Location

The seminar will take place online via the BigBlueButton (BBB) web conferencing system. You can open BBB via a link in your web browser. All you need to do is click on the link to join the seminar. We will send you the link by email in good time. Access will be open from 12:50 p.m.

Event Information

Event Date 15.06.2026 | 13:00 Uhr
Event End Date 15.06.2026 | 14:50 Uhr
Cut Off Date 14.06.2026
Individual Price Free of charge
Programm
13:00 h

Begrüßung
Mandy Ascensi, TransMIT GmbH

13:15 h

Gentherapie - Die rechtliche DNA der Gentherapeutika von der Forschung bis zur Zulassung
Dr. Timo Faltus, Martin-Luther-Universität Halle

14:15 h

From Bench to Biotech – Wie translationale Forschung zum Startup wird
Dr. Anne-Kristin Heninger, Seamless Therapeutics GmbH

14:45 h

Schlussbemerkungen

14:50 h

Ende der Veranstaltung

(Programmänderungen / Ergänzungen vorbehalten)

Das Programm und der Flyer für diese Veranstaltung sind hier als PDF-Datei zu finden.

Organizer

TransMIT Gesellschaft für Technologietransfer mbH

Ihre Ansprechpartnerin:
Dipl.-Biol. Mandy Ascensi
Projektleiterin GO-Bio initial
TransMIT Gesellschaft für Technologietransfer mbH
Kerkrader Straße 3
D-35394 Gießen
Tel. +49 641 94364 36
go-bio-initial@transmit.de

Location Online